Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.

Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.

Item

http://www.wikidata.org/entity/Q33282160

Q33282160

about

Maternal CD4+ cell count decline after interruption of antiretroviral prophylaxis for the prevention of mother-to-child transmission of HIV Immunological responses and long-term treatment interruption after human immunodeficiency virus type 1 (HIV-1) lipopeptide immunization of HIV-1-infected patients: the LIPTHERA study.Improved measures of quality of life, lipid profile, and lipoatrophy after treatment interruption in HIV-infected patients with immune preservation: results of ACTG 5170 Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort Follow-Up Visit Patterns in an Antiretroviral Therapy (ART) programme in Zomba, Malawi.Long-term outcome of patients after a single interruption of antiretroviral therapy: a cohort study.Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy.Acute Human Immunodeficiency Virus (HIV) Syndrome After Nonadherence to Antiretroviral Therapy in a Patient With Chronic HIV Infection: A Case Report.CD4+ T-cell decline after the interruption of antiretroviral therapy in ACTG A5170 is predicted by differential expression of genes in the ras signaling pathway.Implementation and operational research: evaluating outcomes of patients lost to follow-up in a large comprehensive care treatment program in western Kenya.CD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: projecting beyond clinical trials.Facility-Level Factors Influencing Retention of Patients in HIV Care in East Africa.Pentoxifylline reduces tumor necrosis factor-α and HIV-induced vascular endothelial activation.Rapid CD4 decline after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy in a resource-limited setting.Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170).Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy.The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption Brief Report: Relationship Among Viral Load Outcomes in HIV Treatment Interruption Trials.The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African Americans Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial).Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption.EFFECT OF SHORT-TERM ART INTERRUPTION ON LEVELS OF INTEGRATED HIV DNA.

P2860

Q28482652-37495B4E-4970-4AED-ADAD-AE97AD35F46C Q33313949-514B5BD6-99E9-45EE-8644-AEC7DAC5117A Q33377920-CB56F7EB-73EA-430B-92FD-A7137CC92AF5 Q33813911-70A6CA78-058A-425D-B2C6-94A3ED20DC16 Q33916232-E765BAFD-4A72-4808-A8F1-A688C001576D Q34457073-7A46E746-3333-4463-83A5-40A4F38CE8D7 Q34786892-FA91E72A-C374-4226-BC5F-0E7E7089BDFB Q35072026-1755C506-E34F-4634-8BF6-F294AE2D89C6 Q35115062-746EBA31-32C3-4701-A085-655656D8B3EE Q35142277-8B84302C-D532-4D85-94B7-A57F3575CCC1 Q35562938-07470A17-8AE4-47F4-8395-566B402C2C97 Q36100413-8A4E6971-3412-4275-98EC-31398BAFCD12 Q36250376-7A804C69-9769-4ED4-BBDA-99B7370CDA91 Q36398166-910B4361-25B2-497B-8C16-F2BD7040EE2F Q36421569-92554886-8AB3-4ED9-9124-319D2111B1E8 Q36481572-DC1F9EED-2B49-4FAA-9314-3D8E1A03CA52 Q36824388-8B58C1A0-7C31-42BB-BF2A-8ACE551F04F9 Q37014116-EA125B4A-47F8-4762-976C-F709166BE516 Q37186736-9A5D629F-FC39-4992-8179-E33D63C72C92 Q40909527-04DC47A5-621C-4DA0-9426-E798BB95C1A1 Q47553711-A2329C66-86C2-4B00-B120-6134C94964F0 Q52624999-F64AB110-6A8F-42D4-A94C-EAF488FD1CBC

P2860

Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.

Item

http://www.wikidata.org/entity/Q33282160

description

2007 nî lūn-bûn

@nan

2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu